Search research articles
Contact Us
Filters
Showing results (1-10 of 62) with videos related to
Page
of 7
Sort By:
Drug Discovery Today. Technologies
|
July 2, 2014
Use of ribozymes in validation of targets involved in tumor progression
Nadia Zaffaroni, Marco Folini
Methods in Molecular Biology (Clifton, N.J.)
|
March 24, 2009
RNA interference-mediated validation of genes involved in telomere maintenance and evasion of apoptosis as cancer therapeutic targets
Marco Folini, Marzia Pennati, Nadia Zaffaroni
Carcinogenesis
|
March 8, 2007
Targeting survivin in cancer therapy: fulfilled promises and open questions
Marzia Pennati, Marco Folini, Nadia Zaffaroni
Methods in Molecular Biology (Clifton, N.J.)
|
December 19, 2006
Validation of telomerase and survivin as anticancer therapeutic targets using ribozymes and small-interfering RNAs
Nadia Zaffaroni, Marzia Pennati, Marco Folini
Discovery Medicine
|
March 31, 2010
Emerging role of microRNAs in prostate cancer: implications for personalized medicine
Paolo Gandellini, Marco Folini, Nadia Zaffaroni
Biochimica Et Biophysica Acta
|
May 8, 2009
Targeting the telosome: therapeutic implications
Marco Folini, Paolo Gandellini, Nadia Zaffaroni
Trends in Molecular Medicine
|
September 1, 2009
Towards the definition of prostate cancer-related microRNAs: where are we now?
Paolo Gandellini, Marco Folini, Nadia Zaffaroni
Expert Opinion on Therapeutic Targets
|
March 20, 2008
Targeting survivin in cancer therapy
Marzia Pennati, Marco Folini, Nadia Zaffaroni
FEBS Letters
|
July 6, 2015
Double stranded promoter region of BRAF undergoes to structural rearrangement in nearly physiological conditions
Maria Laura Greco, Marco Folini, Claudia Sissi
Current Pharmaceutical Design
|
September 3, 2016
Emerging Role of G-quadruplex DNA as Target in Anticancer Therapy
Graziella Cimino-Reale, Nadia Zaffaroni, Marco Folini
Page
of 7
Search research articles
Search
Showing results (1-10 of 62) with videos related to
Sort By:
Page
of 7
Drug Discovery Today. Technologies
|
July 2, 2014
Use of ribozymes in validation of targets involved in tumor progression
Nadia Zaffaroni, Marco Folini
Methods in Molecular Biology (Clifton, N.J.)
|
March 24, 2009
RNA interference-mediated validation of genes involved in telomere maintenance and evasion of apoptosis as cancer therapeutic targets
Marco Folini, Marzia Pennati, Nadia Zaffaroni
Carcinogenesis
|
March 8, 2007
Targeting survivin in cancer therapy: fulfilled promises and open questions
Marzia Pennati, Marco Folini, Nadia Zaffaroni
Methods in Molecular Biology (Clifton, N.J.)
|
December 19, 2006
Validation of telomerase and survivin as anticancer therapeutic targets using ribozymes and small-interfering RNAs
Nadia Zaffaroni, Marzia Pennati, Marco Folini
Discovery Medicine
|
March 31, 2010
Emerging role of microRNAs in prostate cancer: implications for personalized medicine
Paolo Gandellini, Marco Folini, Nadia Zaffaroni
Biochimica Et Biophysica Acta
|
May 8, 2009
Targeting the telosome: therapeutic implications
Marco Folini, Paolo Gandellini, Nadia Zaffaroni
Trends in Molecular Medicine
|
September 1, 2009
Towards the definition of prostate cancer-related microRNAs: where are we now?
Paolo Gandellini, Marco Folini, Nadia Zaffaroni
Expert Opinion on Therapeutic Targets
|
March 20, 2008
Targeting survivin in cancer therapy
Marzia Pennati, Marco Folini, Nadia Zaffaroni
FEBS Letters
|
July 6, 2015
Double stranded promoter region of BRAF undergoes to structural rearrangement in nearly physiological conditions
Maria Laura Greco, Marco Folini, Claudia Sissi
Current Pharmaceutical Design
|
September 3, 2016
Emerging Role of G-quadruplex DNA as Target in Anticancer Therapy
Graziella Cimino-Reale, Nadia Zaffaroni, Marco Folini
Page
of 7